Blueprint Medicines Corp Uncategorized Contracts & Agreements
9 Contracts & Agreements
- Amendment Agreement dated as of December 23, 2022 by and between the Registrant and Jeffrey W. Albers (Filed With SEC on December 27, 2022)
- Blueprint Medicines Corporation Amended and Restated 2020 Inducement Plan (Filed With SEC on June 27, 2022)
- Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended (Filed With SEC on February 13, 2020)
- [***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE... (Filed With SEC on August 2, 2017)
- [***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE... (Filed With SEC on August 2, 2017)
- *** Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406 (Filed With SEC on November 10, 2016)
- ***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406 (Filed With SEC on August 9, 2016)
- ***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406 (Filed With SEC on November 9, 2015)
- BLUEPRINT MEDICINES CORPORATION SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on March 23, 2015)
